# Imaging Inflammation in Alzheimer's Disease

> **NCT02831283** · PHASE2 · COMPLETED · sponsor: **Patrick Lao** · enrollment: 60 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** 11C-PBR28
- **DRUG:** 18F-Florbetaben
- **PROCEDURE:** Lumbar puncture (optional)

## Key facts

- **NCT ID:** NCT02831283
- **Lead sponsor:** Patrick Lao
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02831283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02831283, "Imaging Inflammation in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02831283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*